Utilizing self-prepared ELISA plates for a cross-population study of different anti-HBe IgG subclass profiles

Journal of Medical Virology

Volumn 79, Issue 5, 2007, Pages 495-502

  Wang, Lina ^a   Tsai, Tzu Hsin ^a   Huang, Chien Fu ^b   Ho, Mei Shang ^c   Lin, Ding Bang ^a   Ho, Yung Chyuan ^a   Lin, Shih Shen ^d   Wei, James Cheng Chung ^a,d   Chou, Ming Chih ^a   Yang, Chi Chiang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ALT; Anti HBe; AST; ELISA; HBV; IgG subclass

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DODECYL SULFATE SODIUM; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; VIRUS CARRIER; VIRUS NEUTRALIZATION;

BIOLOGICAL MARKERS; CARRIER STATE; CONVALESCENCE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULIN G; MALE; RETROSPECTIVE STUDIES;

HEPATITIS B VIRUS;

EID: 34147124210     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20852     Document Type: Article

References (34)

1. Aalberse RC, van der Gaag R, van Leeuwen J. 1983. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130:722-726.
2. Akbar SMF, Horiike N, Onji M, Ohta Y. 1991. Immunoglobulin G subclasses of antibodies to hepatitis B core antigen in HBs antigen positive liver diseases. J Gastroenterol Hepatol 6:71-75.
3. Borzi RM, Dal Mote P, Honorati MC, Facchini A. 1992. IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HBs Ag. J Immunol Meth 46:17-23.
4. Bozkaya H, Bozdayi M, Turkyilmaz R, Sarioglu M, Cetinkaya H, Cinar K, Kose K, Yurdaydin C, Uzunalimoglu O. 2000. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: Their relations to HBeAg status and the activity of liver disease. Hepatogastroenterol 47:1675-1679.
5. Carotenuto P, Quinti I, Pontesilli O, Hall AJ, De Lange GG, Whittle HC, D'Amelio R, Aiuti F. 1995. Response to hepatitis B vaccine in a cohort of Gambian children. Pediatr Infect Dis 14:215-220.
6. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathegenesis. Ann Rev Immunol 13:29-60.
7. Ethel CS, Dolores B, Patricia B, Viviana NS, Victorio PJ. 2004. Immune response of IgG antibodies at the persistence and reactivation stages of human herpes virus 6 infection. J Clin Virol 31:266-269.
8. Finkelman FD, Sevtic A, Gresser I, Snapper C, Holmes J, Trotta PP, Katona IM, Gause WC. 1991. Regulation by interferon α of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 174:1179-1188.
9. Funk ML, Rosenberg DM, Lok ASF. 2002. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Virol Hepat 9:52-61.
10. Gregorek H, Madalinski K, Woynarowski M, Mikolajewicz J, Syczewska M, Socha J. 2000. IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-alpha therapy. J Infect Dis 181:2059-2062.
11. Grigorescu-Sido P, Calin L, Manasia R, Mirestean S, Cret V, Skorka C, Grigorescu-Sido A. 2002. Results of interferon treatment in children with chronic hepatitis B. Rom J Gastroenterol 11:285-290.
12. Hadziyannis SJ, Vassilopoulos D. 2001. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34:617-624.
13. Heijtink RA, Janssen HL, Hip WC, Osterhaus AD, Schalm SW. 2001. Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication. J Med Virol 63:217-219.
14. Hollinger FB, Liang TJ. 2001. Hepatitis B virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins. pp 2971-3036.
15. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35:1522-1527.
16. Hultgren C, Milich DR, Weiland O, Sallberg M. 1998. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 79:2381-2391.
17. Khalife J, Guy B, Capron M, Kieny MP, Ameisen JC, Montagnier L, Lecocq JP, Capron A. 1988. Isotypic restriction of the antibody-response to human immunodeficiency virus. AIDS Res Hum Retroviruses 4:3-9.
18. Linde A, Sundqvist VA, Mathiesen T, Wahren B. 1988. IgG subclasses to subviral components. Monogr Allergy 23:27-32.
19. MacKay P, Lees J, Murray K. 1981. The conversion of hepatitis B core antigen synthesized in E coli into e antigen. J Med Virol 8:237-243.
20. Milich DR, Jones J, Hughes J, Maruyama T. 1993. Role of T cell tolerance in the persistence of hepatitis B virus infection. J Immunother 14:226-233.
21. Milich DR, Schödel F, Hughes JL, Jones JE, Peterson DL. 1997. The hepatitis B virus core and e antigens elicit different Th cell subsets: Antigen structure can affect Th cell phenotype. J Virol 71:2192-2201.
22. Milich DR, Chen MK, Hughes JL, Jones JE. 1998. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: A mechanism for persistence. J Immunol 160:2013-2021.
23. Miyakawa Y, Mayumi M. 1985. Hepatitis B e antigen and antibody (HBeAg/Anti-HBe). In: Gerety RH, editors. Hepatitis B. Orlando: Academic Press, pp 47-76.
24. Miyakawa Y, Okamoto H, Mayumi M. 1997. The molecular basis of hepatitis Be antigen (HBeAg)-negative infections. J Viral Hepatitis 4:1-8.
25. Rico MA, Quiroga JA, Subira D, Castanon S, Esteban JM, Pardo M, Carreno V. 2001. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-Positive patients treated with ribavirin and interferon alpha. Hepatology 33:295-300.
26. Sällberg M, Norder H, Magnius LO. 1990. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B. J Med Virol 30:1-6.
27. Sundqvist VA, Linde A, Wahren B. 1984. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol 20:94-98.
28. Tsai TH, Huang CF, Wei JCC, Ho MS, Wang L, Tsai WY, Lin CC, Xu FL, Yang CC. 2006. The study of IgG subclass profiles of anti-HBs in populations with different status of HBV infection. Viral Immunol 19:277-284.
29. van Loon AM, Heessen FWA, van der Logt JTM. 1987. Antibody isotype response after human cytomegalovirus infection. J Virol Methods 15:101-107.
30. Wagner DK, Nelson DL, Walsh EE, Reimer CB, Henderson FW, Murphy BR. 1987. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults. J Clin Microbiol 25:748-750.
31. Wang L, Lin SJ, Tsai JH, Tsai CH, Tsai CC, Xu FL, Yang CC. 2005. Anti-HBs IgG1 subclass is predominant in HBV recovered patients, chronic carriers and vaccinees by evaluating self-prepared ELISA plates. Med Microbiol Immunol 194:33-38.
32. Yalcin K, Degertekin H, Alp MN, Tekes S, Satici O, Budak T. 2003. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers. Turk J Gastroenterol 14:157-163.
33. Yang CC, Lin CC, Wang L, Ku CS, Chen CK. 2001. Anti-HBc IgG subclasses in different populations by comparing a variety of ELISA plates. J Immunoassay Immunochem 22:33-45.
34. Yang YY, Huang CF, Wei JCC, Ho MS, Wang L, Lin SJ, Tsai WY, Lin CC, Xu FL, Yang CC. 2005. The study of IgG subclass profiles of anti-HBc in populations with different status of HBV infection. Cell Mol Immunol 2:393-398.